SLC37A3 Knockout HEK293 Cell Line
Cat.No.:
EDC09849
Species:
Human
Cell Name:
HEK293
Gene:
SLC37A3
Gene ID:
84255
Size:
1×10⁶cells
SLC37A3 Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC09849 |
|---|---|
| Product Name | SLC37A3 Knockout Cell Line (HEK293) |
| Cell Line | HEK293 |
| Cellosaurus ID | CVCL_0045 |
| Cell Line Synonyms | Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 |
| Gene | SLC37A3 |
| NCBI Gene ID | |
| Gene Synonyms | SPX3 |
| Summary |
Enables xenobiotic transmembrane transporter activity. Involved in xenobiotic transmembrane transport. Located in endoplasmic reticulum membrane and lysosomal membrane. [provided by Alliance of Genome Resources, Jul 2025]
|
| Associated Diseases | Non-tumor |
| Morphology | Adherent |
| Passage Ratio | 1/5,2days |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 95% Complete culture medium+ 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293 | STR Info (Cell bank) Cell Line: HEK293 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 12 | 11 | 12 | |
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 8 | 8 | 9 | |
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 13 | 9 | 13 |
| D18S51 | 17 | 18 | 17 | 18 |
| D19S433 | 15 | 18 | 15 | 18 |
| D21S11 | 28 | 30.2 | 28 | 30.2 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 10 | 9 | 10 |
| Penta E | 7 | 15 | 7 | 15 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 11 | 11 | ||
| vWA | 16 | 19 | 16 | 19 |
| D6S1043 | 11 | 11 | ||
| D12S391 | 19 | 21 | 11 | 15 |
| D2S441 | 11 | 15 | 11 | 15 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC37A3 function, SLC37A3 Knockout HEK293 Cell Line or SLC37A3 overexpression HEK293 Cell Line?
The choice depends on whether you are studying SLC37A3's role as a putative phosphate/glucose-6-phosphate ER transporter or its emerging functions in lysosomal/ER compartment biology. The Knockout line is appropriate for asking whether SLC37A3 is required for these activities, though its substrate specificity is less defined than its SLC37A4 (G6PT) paralog. Overexpression is useful for testing transport activity in heterologous systems.
For SLC37 family research, the EDITGENE Knockout in HEK293 provides a clean background for biochemical and functional studies. SLC37A3 has been reported to participate in lysosomal compartment biology in some contexts. Rescue with wild-type SLC37A3 enables initial functional characterization and substrate scope studies.
What are the application scenarios for this model?
Primary applications:
• Putative phosphate-sugar transport: in vitro transport assays with candidate substrates to characterize SLC37A3 transport activity.
• Subcellular localization: imaging-based analysis of SLC37A3 trafficking and compartment targeting.
• Comparative SLC37 family studies: parallel analysis with SLC37A4 to dissect family-specific functions.
• Substrate discovery: untargeted metabolomics to identify candidate substrates by detecting altered intracellular metabolite levels.
EDITGENE recommends this model for researchers investigating SLC37 family transporter biology and ER/lysosomal phosphate-sugar transport mechanisms.
Is this SLC37A3 Knockout HEK293 Cell Line compatible with overexpression rescue experiments?
Yes. SLC37A3 rescue experiments require attention to MFS family architecture:
• Construct design: use a codon-modified SLC37A3 sequence with a small C-terminal tag (FLAG, HA). The predicted MFS transporter architecture should be preserved.
• Localization validation: confirm subcellular localization (ER, lysosomal, or plasma membrane) by appropriate compartment marker co-staining.
• Transport-deficient rescue: conserved MFS family residue mutations enable structure-function studies.
• Functional readout: rescue should restore phenotypes identified during knockout phenotype characterization; substrate-specific transport assays test predicted activities.
HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.